ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,120, issued on Oct. 20.

"Compositions for and methods of precision cancer treatment" was invented by Stanislaw R. Burzynski (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising one or more antineoplastons and using those compositions in methods of treating and/or preventing cancer, prolonging the survival of a subject, and preventing and/or decreasing metastasis of cancer."

The patent was filed on Dec. 2, 2022, under Application No. 18/073,944.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...